Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis.

Gelhard, Savannah; Maxwell, Amiee; Colman, Howard; Cohen, Adam L; Mendez, Joe S

Gelhard, Savannah; Maxwell, Amiee; Colman, Howard; Cohen, Adam L; Mendez, Joe S.

Afiliação

Gelhard S; School of Medicine, University of Utah, Salt Lake City, UT, USA.
Maxwell A; Total Cancer Care Department, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Colman H; Winona State University, Winona, MN, USA.
Cohen AL; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Mendez JS; Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

J Neurooncol ; 159(2): 293-300, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35764907

Assuntos

Neoplasias do Sistema Nervoso Central; Linfoma; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica; Sistema Nervoso Central; Análise Custo-Benefício; Citarabina; Humanos; Metotrexato; Estudos Retrospectivos

Palavras-chave

Consolidation; Cost-benefit analysis; Primary central nervous system lymphoma; Value-driven outcome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Linfoma Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google